dalteparin has been researched along with Invasiveness, Neoplasm in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " These assays may provide useful markers to guide appropriate dalteparin (and other low-molecular weight heparin) dosing schedules to optimize anticancer effects of dalteparin in APC." | 2.75 | Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serum-mediated induction of cancer cell invasion. ( Echrish, H; Ettelaie, C; Gardiner, E; Greenman, J; Li, C; Madden, LA; Maraveyas, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, GX | 1 |
| Gong, Y | 1 |
| Yu, CJ | 1 |
| Wu, SF | 1 |
| Ma, QP | 1 |
| Wang, Y | 1 |
| Ren, J | 1 |
| Zhang, XC | 1 |
| Yang, WH | 1 |
| Zhu, W | 1 |
| Zhuang, X | 1 |
| Qiao, T | 1 |
| Xu, G | 1 |
| Yuan, S | 1 |
| Zhang, Q | 1 |
| Chen, X | 1 |
| Sengodan, P | 1 |
| Grewal, H | 1 |
| Gandhi, S | 1 |
| Patel, N | 1 |
| Singhal, D | 1 |
| Ma, L | 1 |
| Qiao, H | 1 |
| He, C | 1 |
| Yang, Q | 1 |
| Cheung, CH | 1 |
| Kanwar, JR | 1 |
| Sun, X | 1 |
| Balzarotti, M | 1 |
| Fontana, F | 1 |
| Marras, C | 1 |
| Boiardi, A | 1 |
| Croci, D | 1 |
| Ciusani, E | 1 |
| Salmaggi, A | 1 |
| Maraveyas, A | 1 |
| Ettelaie, C | 1 |
| Echrish, H | 1 |
| Li, C | 1 |
| Gardiner, E | 1 |
| Greenman, J | 1 |
| Madden, LA | 1 |
1 trial available for dalteparin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Weight-adjusted dalteparin for prevention of vascular thromboembolism in advanced pancreatic cancer patients decreases serum tissue factor and serum-mediated induction of cancer cell invasion.
Topics: Aged; Dalteparin; Disease Progression; Female; Humans; Male; Middle Aged; Molecular Weight; Neoplasm | 2010 |
6 other studies available for dalteparin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.
Topics: Actin Cytoskeleton; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Adhesion; Cell Movement; C | 2015 |
Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Basigin; Cell Movement; Cell Prolifer | 2016 |
Invasive hepatocellular carcinoma with recurrent pulmonary embolism: use of AngioVac cannula thrombectomy device for mechanical aspiration.
Topics: Adult; Angiography; Anticoagulants; Antineoplastic Agents; Carcinoma, Hepatocellular; Enoxaparin; Fa | 2014 |
Activated clotting time monitoring during osteocutaneous free fibula flap surgery.
Topics: Aged; Anticoagulants; Blood Coagulation; Carcinoma, Squamous Cell; Enoxaparin; Facial Neoplasms; Fem | 2015 |
Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Movement; Cell Proliferation; Chemokine CXCL12; | 2012 |
In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas.
Topics: Adolescent; Adult; Aged; Apoptosis; Brain Neoplasms; Cell Proliferation; Dose-Response Relationship, | 2006 |